Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Simvastatin: a review.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
In Vivo Brain MR Imaging at Subnanoliter Resolution: Contrast and Histology.
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis (ASCEND in SPMS)
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
The refinement of genetic predictors of multiple sclerosis.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Assessing upper limb function in multiple sclerosis.
Dilantin (phenytoin) Supplemental Approval Letter
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »